Anamorelin
- 3 trials, none about aging
Development
- Companies
- Helsinn HealthcarePhase 3cachexia; cancer, non-small cell lung cancer
Trial sponsors
Company2 trialsPhase 3636 people
1 trialPhase 2/325 people
Latest
1 in 12 monthsFrontiers in Aging Neuroscience
Systemic proteomic and organ aging signatures associated with plasma Aβ oligomerization in a Korean cohort: a cross-sectional study
Cross-sectional study of 40 peopleBiomarkers
Journal of Cachexia, Sarcopenia and Muscle
Sarcopenia in Ageing and Chronic Illness: Trial Endpoints and Regulatory Issues
ReviewIndustry & policy